Roivant (NASDAQ: ROIV) president settles RSU taxes in shares

Rhea-AI Filing Summary

Roivant Sciences Ltd. (ROIV) reported an insider equity event involving Eric Venker, President & Immunovant CEO. On 2026-08-20, 13,909 common shares were withheld in a code F transaction at $36.84 per share as a net settlement of RSUs to cover tax withholding upon vesting. Following this withholding, Venker’s directly held stake is reported as 1,599,154 common shares. This reflects tax-related share settlement rather than an open-market sale.

Insider Trade Summary

Net Seller: 13,909 shares

Net Sell 1 txn

Insider Venker Eric

Role President & Immunovant CEO

Type	Security	Shares	Price	Value
Tax Withholding	Common Shares F1	13,909	$36.84	$512K

Holdings After Transaction: Common Shares — 1,599,154 shares (Direct)

Footnotes (1)

1. F1. Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

Key Figures

Shares withheld for tax settlement: 13,909 shares Per-share value in tax withholding: $36.84 per share Shares held after transaction: 1,599,154 shares

3 metrics

Shares withheld for tax settlement 13,909 shares Common shares withheld on 2026-08-20 in a code F transaction

Per-share value in tax withholding $36.84 per share Value applied to 13,909 common shares in the RSU net settlement

Shares held after transaction 1,599,154 shares Directly held Roivant Sciences common shares following the 2026-08-20 event

Key Terms

Restricted Stock Units, net settlement, tax withholding obligations

3 terms

Restricted Stock Units financial

"Represents the "net settlement" by the Issuer of RSUs previously granted"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

net settlement financial

"Represents the "net settlement" by the Issuer of RSUs previously granted"

tax withholding obligations financial

"in order to satisfy applicable tax withholding obligations in connection"

FAQ

What insider transaction did ROIV report for Eric Venker on August 20, 2026?

Roivant Sciences Ltd. reported that Eric Venker had 13,909 common shares withheld in a code F transaction on 2026-08-20 at $36.84 per share, as a tax-withholding net settlement of vested RSUs rather than an open-market sale.

Did Eric Venker sell Roivant Sciences (ROIV) shares in the open market?

No. The filing shows a code F transaction where 13,909 shares were withheld to satisfy tax withholding obligations on vested RSUs. The footnote describes it as a “net settlement” by the issuer, not an open-market sale by Venker.

How many Roivant Sciences (ROIV) shares does Eric Venker hold after this transaction?

After the tax-withholding settlement, Eric Venker is reported as directly holding 1,599,154 common shares of Roivant Sciences Ltd., according to the post-transaction ownership figure in the Form 4.

What does the $36.84 figure represent in the ROIV Form 4 filing?

The filing reports a $36.84 per share figure for the 13,909 Roivant Sciences common shares withheld. It is the per-share value used in the tax-withholding net settlement of the vested RSUs.

What is the nature of the RSU transaction reported for ROIV?

The footnote explains that the event reflects a “net settlement” of RSUs previously granted to Eric Venker, where the issuer withheld 13,909 shares to cover applicable tax withholding obligations upon vesting and settlement of those RSUs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/24/2026 - 09:00 PM Accepted by SEC EDGAR 08/24/2026 - 09:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Venker Eric

(Last) (First) (Middle)

C/O ROIVANT SCIENCES LTD.

7TH FLOOR, 50 BROADWAY

(Street)

LONDON SW1H 0DB

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Roivant Sciences Ltd. [ ROIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & Immunovant CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/20/2026		F		13,909(1)	D	$36.84	1,599,154	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

	By: /s/ Sam Kaplan, as Attorney-in-Fact for Eric Venker	08/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)